Financial results - NORD PHARMA S.R.L.

0.00
Financial Summary - Nord Pharma S.r.l.
Unique identification code: 14477809
Registration number: J27/90/2002
Nace: 4646
Sales - Ron
961.352
Net Profit - Ron
276.577
Employee
6
Open Account
The most important financial indicators for the company Nord Pharma S.r.l. - Unique Identification Number 14477809: sales in 2023 was 961.352 euro, registering a net profit of 276.577 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nord Pharma S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 697.980 766.701 838.498 863.914 861.965 902.085 871.704 812.047 936.460 961.352
Total Income - EUR 698.696 767.483 839.475 864.239 862.438 902.842 872.092 812.465 940.669 963.061
Total Expenses - EUR 527.687 600.262 642.013 659.862 675.639 683.949 640.013 605.807 700.928 648.826
Gross Profit/Loss - EUR 171.009 167.221 197.462 204.377 186.799 218.893 232.080 206.658 239.741 314.235
Net Profit/Loss - EUR 141.490 134.738 163.385 169.822 178.174 209.864 224.020 199.265 231.246 276.577
Employees 11 12 13 13 10 8 8 7 6 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 3.0%, from 936.460 euro in the year 2022, to 961.352 euro in 2023. The Net Profit increased by 46.031 euro, from 231.246 euro in 2022, to 276.577 in the last year.
See Company Data

Check the financial reports for the company - Nord Pharma S.r.l.

Rating financiar

Rating financiar -
Nord Pharma S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nord Pharma S.r.l. - CUI 14477809

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 224.768 142.258 152.805 168.079 190.237 210.367 215.403 235.116 228.082 243.718
Current Assets 697.185 704.227 723.964 890.464 874.009 695.224 866.454 851.557 612.287 805.823
Inventories 45.475 53.367 59.049 72.212 68.657 66.691 67.416 65.979 89.505 89.448
Receivables 248.593 290.492 306.371 293.702 283.067 280.979 281.021 292.976 398.221 440.695
Cash 403.117 360.368 358.543 524.550 522.286 347.553 518.017 492.602 124.561 275.680
Shareholders Funds 722.164 714.561 166.046 169.866 344.923 550.916 763.148 829.952 603.468 870.503
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 226.164 226.070 803.442 946.822 749.632 345.215 280.944 183.900 160.517 169.376
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 805.823 euro in 2023 which includes Inventories of 89.448 euro, Receivables of 440.695 euro and cash availability of 275.680 euro.
The company's Equity was valued at 870.503 euro, while total Liabilities amounted to 169.376 euro. Equity increased by 268.865 euro, from 603.468 euro in 2022, to 870.503 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.